RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective

Aravind Kumar Subramanian, Xavier Christu Rajan.V

2020, Vol: 11, Issue: 3

11 / 3Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Author Contribution Form _(v2r)_
Copyright Form_(v2r)_

« Previous Article

Original Research (Original Article)

. 2020; 11(3): 99-100

doi: 10.31838/jcdr.2020.11.03.23

RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective

Aravind Kumar Subramanian, Xavier Christu Rajan.V.

Abstract
Novel Corona virus (COVID-19) caused global outbreak and affected the health of many individuals and caused millions of death worldwide. World health organisation announced this disease as pandemic virus. This disease was first reported in Hubei Province on December at Wuhan, China. Within a short span the disease spread across 177 countries across the globe and World health organisation reported 16,755,633 confirmed cases and 661244 deaths as on 29th July 2020. Respiratory illness and mild flu like symptoms are mostly common symptoms of COVID-19. It also affects the cardiovascular status especially the individual with pre-existing cardiovascular disease. Direct myocardial injury is observed and appearance of inflammation is the primary mechanism involved for Cardiac injury. This review enlightens the role of RAAS Inhibitors like ACE-Is, ARBs and statins in COVID-19 pandemic.

Key words: Novel Corona virus, COVID-19, Cardiovascular, RAAS inhibitors, Statins

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Aravind Kumar Subramanian Articles by Xavier Christu Rajan.V
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. . 2020; 11(3): 99-100. doi:10.31838/jcdr.2020.11.03.23

Web Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. http://www.jcdronline.org//?mno=118031 [Access: August 02, 2020]. doi:10.31838/jcdr.2020.11.03.23

AMA (American Medical Association) Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. . 2020; 11(3): 99-100. doi:10.31838/jcdr.2020.11.03.23

Vancouver/ICMJE Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. . (2020), [cited August 02, 2020]; 11(3): 99-100. doi:10.31838/jcdr.2020.11.03.23

Harvard Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V (2020) RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. , 11 (3), 99-100. doi:10.31838/jcdr.2020.11.03.23

Turabian Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. 2020. RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. Journal of Cardiovascular Disease Research, 11 (3), 99-100. doi:10.31838/jcdr.2020.11.03.23

Chicago Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. "RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective." Journal of Cardiovascular Disease Research 11 (2020), 99-100. doi:10.31838/jcdr.2020.11.03.23

MLA (The Modern Language Association) Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V. "RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective." Journal of Cardiovascular Disease Research 11.3 (2020), 99-100. Print. doi:10.31838/jcdr.2020.11.03.23

APA (American Psychological Association) Style

Aravind Kumar Subramanian, Xavier Christu Rajan.V (2020) RAAS Inhibitors and Statins in COVID-19 Pandemic -A Perspective. Journal of Cardiovascular Disease Research, 11 (3), 99-100. doi:10.31838/jcdr.2020.11.03.23

Most Viewed Articles

Reduced nitrate level in individuals with hypertension and diabetes
Shiekh Gazalla Ayub, Taha Ayub, Saquib Naveed Khan, Rubiya Dar, Khurshid Iqbal Andrabi
. 2011; 2(3): 172-176
» Abstract » doi: 10.4103/0975-3583.85264

Association of statin therapy with blood pressure control in hypertensive hypercholesterolemic outpatients in clinical practice
Manuel Morgado, Sandra Rolo, Ana Filipa Macedo, Miguel Castelo-Branco
. 2011; 2(1): 44-49
» Abstract » doi: 10.4103/0975-3583.78596

Abdominal obesity, an independent cardiovascular risk factor in Indian subcontinent: A clinico epidemiological evidence summary
D. S. Prasad, Zubair Kabir , A. K. Dash, B. C. Das
. 2011; 2(4): 199-205
» Abstract » doi: 10.4103/0975-3583.89803

Utilization of Real-time 3D Transesophageal Echocardiography in an Urban Academic Medical Center
Lili Zhang, Elaine Y. Lin, Dron Bhandari, Mohan Pamerla, George K. Lui, Cynthia C. Taub
. 2014; 5(2): 9-14
» Abstract » doi: 10.5530/jcdr.2014.2.3

High prevalence of cardiovascular diseases among other medically compromised conditions in dental patients: A retrospective study
Sumit Bhateja
. 2012; 3(2): 113-116
» Abstract » doi: 10.4103/0975-3583.95364

Most Downloaded

Review Article: Impact of Ivabradine on Cardiovascular Morbidity
Gammone M, Riccioni G, D’Orazio
. 2020; 11(1): 4-8
» Abstract » doi: 10.5530/jcdr.2020.11.02

Vascular Endothelial Growth Factor and its Soluble Receptor-1 as Surrogate Markers for Subjects with High-risk of Cardiovascular Disease
Vipa Boonkitticharoen, Chanika Sritara, Prin Vathesatogkit, Supakajee Saengruang-Orn,Wipa Ratanachaiwong, Piyamitr Sritara
. 2014; 5(2): 35-42
» Abstract » doi: 10.5530/jcdr.2014.2.8

Study of Metabolic Syndrome and Its Components Among Kurnool District Population of Andhra Pradesh with Different Ethnic Backgrounds
Pandit Vinodh Bandela, Nilima Nandakumar Dongre, Jeevan Gangadhar Ambekar, Kedam Durga Prasad, Basavaraj B Devaranavadagi
. 2017; 8(3): 83-88
» Abstract » doi: 10.5530jcdr.2017.3.20

Diagnosis and surgical treatment of carotid body tumor: A report of 18 cases
Dan Ma, Min Liu, Hua Yang, Xiaogan Ma, Chaojun Zhang
. 2010; 1(3): 122-124
» Abstract » doi: 10.4103/0975-3583.70905

P2Y receptors as regulators of lung endothelial barrier integrity
Evgeny Zemskov, Rudolf Lucas Alexander D. Verin, Nagavedi S. Umapathy
. 2011; 2(1): 14-22
» Abstract » doi: 10.4103/0975-3583.78582

Most Cited Articles

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Journal of Cardiovascular Disease Research are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Copyright © 2020 Journal of Cardiovascular Disease Research All Rights Reserved. Subject to change without notice from or liability to Journal of Cardiovascular Disease Research. For best results, please use Internet Explorer or Google Chrome	Contact Information Branch Office/Support Office for journal: Journal of Cardiovascular Disease Research Publication Office Advanced Scientific Research, 21, Thyamotharan Street, Arisipalayam Salem - 636009 Email : editor@jcdronline.org support : support@jcdronline.org

POLICIES & JOURNAL LINKS

Author Login
Reviewer Login
About Publisher
Advertising Policy
Author's Rights and Obligations
Conflict of Interest Policy
Digital Archiving & Preservation Policies
Editorial Policies
Peer Review Policy
Editorial & Peer Review Process
License Information
Plagiarism Policy
Privacy Policy
Protection of Research Participants (Statement On Human And Animal Rights)
Publication Ethics and Publication Malpractice Statement
Corrections, Retractions & Expressions of Concern
Self-Archiving Policies
Statement of Informed Consent
Terms of Use

Contact Information

How to cite this article